The sold production of medicaments containing vitamins, provitamins, derivatives, and intermixtures thereof in Germany is forecasted to experience a steady increase from 2024 to 2028, with values rising from 3.96 billion euros in 2024 to 4.42 billion euros in 2028. In 2023, this figure stood at approximately 3.85 billion euros, marking a consistent upward trajectory.
The year-on-year growth percentages indicate an average annual increase, reflecting a robust demand in the sector. The five-year Compound Annual Growth Rate (CAGR) further reinforces this steady growth pattern.
Future trends to watch for:
- Continued innovation in vitamin and supplement formulations, which may drive demand.
- The impact of regulatory changes on production and sales within the medicaments sector.
- Shifts in consumer health consciousness and preferences influencing market dynamics.
